Trial Profile
A Phase 2 Extension of Study GCS-100-CS-4003
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2015
Price :
$35
*
At a glance
- Drugs GCS 100 (Primary)
- Indications Renal failure
- Focus Adverse reactions
- Sponsors La Jolla Pharmaceutical Company
- 13 Jan 2015 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to withdrawn prior to enrolment.
- 13 Jan 2015 New trial record